Harrow Health, Inc.: Company Investigated by the Portnoy Law Firm


Investors can contact the law firm at no cost to learn more about recovering their losses

LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Harrow Health, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Harrow investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

Bonitas Research released a report on February 22, 2023, which claimed that Harrow had kept quiet about a U.S. Department of Justice investigation into its sales practices and had engaged in questionable transactions with former subsidiaries. Additionally, Harrow had not revealed that it received a warning letter from the U.S. Food and Drug Administration for misleading marketing claims. However, months later, the company issued a recall across the country. As a result of this news, Harrow's stock price dropped by 3.2%, or $0.54, to close at $16.42 on February 22, 2023, causing harm to investors.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising